ZTZhaoxu Tu

Zhaoxu Tu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhaoxu Tu has a total of 115 co-authors. Here are the top co-authors by number of shared publications:

  • Ming Liu

    Department of Otolaryngology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510655, China; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510655, China; Key Laboratory of Human Microbiome and Chronic Diseases (Sun Yat-sen University), Ministry of Education, 510655, China

    10 shared publications
  • Changyi Xu

    Department of Otolaryngology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510655, China; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510655, China; Key Laboratory of Human Microbiome and Chronic Diseases (Sun Yat-sen University), Ministry of Education, 510655, China

    9 shared publications
  • Rainer Haag

    Institute of Chemistry and Biochemistry Freie Universität Berlin Berlin Germany

    7 shared publications
  • Yuefei Zhu

    7 shared publications
  • Jian Li

    Department of Otolaryngology The First Affiliated Hospital Sun Yat‐Sen University Guangzhou China

    6 shared publications
  • Kam W. Leong

    Columbia University

    6 shared publications

Latest Publications

  • Disrupting neuro-immune crosstalk through cfDNA/NETs degradation by Zr4+-based nanoenzymes: A therapeutic strategy for airway inflammatory disorders

    by Yang Ye, Ming Liu, Hua Zhong, Changyi Xu, Kaiqiao Liang, Junyan Lin, Xinran Xie, Zixuan Huang, Zihan Qiu, Jie Liu, et al.


  • Open Access

    Surmounting Recalcitrant Airway Inflammatory Disorders With a Multi‐Targeting Therapeutic Strategy by Tannic Acid‐Modified CuInP 2 S 6 Nanosheets

    by Ming Liu, Changyi Xu, Renqiang Ma, Xinran Xie, Ying Xie, Mengya Du, Zhaofeng Xu, Shuaiyin Zhang, Jian Li, Weiping Wen, et al.

    Recalcitrant airway inflammatory diseases have drawn significant attention due to their high incidence and substantial healthcare costs. Analysis of clinical samples from patients with chronic rhinosinusitis with nasal polyps (CRSwNP) revealed the coexistence of neutrophilic and eosinophilic inflammation, which may account for the limited efficacy of traditional single‐target therapeutic strategies. Moreover, cell‐free DNA (cfDNA)—an emerging inflammatory mediator—has been implicated in both eosinophilic and neutrophilic responses through its role in the formation of extracellular traps. In this study, we developed tannic acid (TA)‐modified CuInP 2 S 6 (CIPS) nanosheets (C‐TA 1 ; w/w = 1:1) as a multi‐targeting therapeutic nanoplatform for recalcitrant airway inflammatory diseases. The C‐TA 1 nanosheets demonstrated efficient cfDNA clearance via hydrogen bonding interactions, thereby inhibiting cfDNA‐triggered toll‐like receptor 9 (TLR9) activation and subsequent nuclear factor‐κB (NF‐κB) inflammatory signaling. Additionally, C‐TA 1 exhibited potent antioxidant and antibacterial activities, which were ascribed to the inherent properties of the two‐dimensional nanostructure and the chemical characteristics of TA, respectively. The in vivo therapeutic efficacy of C‐TA 1 was evaluated in murine models with neutrophilic and eosinophilic airway inflammation, respectively. C‐TA 1 markedly attenuated airway inflammation in both of these animal models by reducing reactive species, immune cell infiltration, goblet cell hyperplasia and the expression of pro‑inflammatory cytokines. Furthermore, treatment with C‐TA 1 effectively modulated the dysregulated airway microbiota observed in the inflammatory state. Our findings demonstrate a multi‐targeting nanoformulation designed to mitigate multiple key pathological drivers of severe airway inflammation concurrently. This engineered system presents a promising strategy for managing respiratory inflammatory disorders and also other inflammation‐related diseases.


  • Open Access

    Author Correction: Nanostructured organic sheets sequestering small extracellular vesicles and reactive species to protect against radiation-induced mucositis

    by Yuefei Zhu, Changyi Xu, Zhixin Li, Xiaomin Bao, Ming Liu, Yangyang She, Renqiang Ma, Xiangzhen Liu, Jian Li, Weiping Wen, et al.


  • Correction to “Tackling Severe Neutrophilic Inflammation in Airway Disorders with Functionalized Nanosheets”

    by Zhaoxu Tu, Yuefei Zhu, Wenlong Gao, Ming Liu, Yi Wei, Changyi Xu, Yongqiang Xiao, Yihui Wen, Jian Li, Kam W. Leong, et al.

  • Open Access

    Tackling Allergic Airway Inflammation with Organic Sheet‐Like Nanoplatforms by Targeted Elimination of Epithelial Small Extracellular Vesicles

    by Zhaoxu Tu, Junyan Lin, Zhixin Li, Yuefei Zhu, Changyi Xu, Zihan Qiu, Qiumin Wang, Yang Ye, Yihui Wen, Jian Li, et al.

    Allergic airway inflammatory disorders, such as allergic rhinitis (AR) and asthma, affect the health of more than one billion people worldwide, yet therapeutic outcomes remain unsatisfactory. 2D nanomaterials are extensively adopted in biomedical research, but their inorganic components often limit clinical applications. To address these challenges, functionalized “inorganic‐free” nanosheets PNS E are developed as a potential strategy for alleviating allergic inflammation via targeted elimination of epithelial small extracellular vesicles (sEVs). PNS E are prepared using template‐based synthesis technology and modified with epidermal growth factor receptor aptamers, which exhibit low cytotoxicity, mild protein adsorption, and potent epithelial sEVs binding efficacy. PNS E suppresses sEVs‐triggered stimulator of interferon genes activation, alleviating the dendritic cell maturation and eosinophil extracellular trap formation in vitro. In addition, PNS E displays exceptional biocompatibility, preferential airway localization, and robust modulation for allergic airway inflammation in vivo. Transcriptome analysis and multi‐channel flow cytometry of airway tissues further confirm the alleviation of dysregulated airway inflammation in house dust mite‐stimulated animal models. These results highlight the pivotal feature of the organic sheet‐like nanoplatforms for targeted clearance of epithelial sEVs, which can be exploited as a nanomedicine for the treatment of allergic airway inflammation and also other allergic disorders.


  • Open Access

    Targeting Neutrophil/Eosinophil Extracellular Traps by Aptamer‐Functionalized Nanosheets to Overcome Recalcitrant Inflammatory Disorders

    by Yongqiang Xiao, Xinyue Wang, Ming Liu, Xiao Fu, Nanfeng Zhang, Wenqing Yang, Junyi Ge, Yangyang Li, Duan Ma, Jing Ma, et al.

    Excessive generation of neutrophil extracellular traps (NETs) and eosinophil extracellular traps (EETs) can drive various inflammatory disorders by stimulating intracellular nucleic acid receptors. Although extracellular traps (ETs) are promising therapeutic targets for recalcitrant chronic inflammation, for example, otitis media with effusion (OME), practical and specific targeting of NETs/EETs in pathological tissues remains challenging. In this study, an ultrathin, 2D sheet‐like nanoscavenger C‐TA H is developed by modifying copper indium thiophosphate (CIPS) nanosheets with tannic acid (TA) and histone aptamers. The findings reveal that C‐TA H effectively binds the dsDNA of NETs/EETs, inhibits bacterial growth, and reduces reactive oxygen species (ROS) levels, leading to a depressed local inflammation in ovalbumin (OVA)‐induced OME rats. In addition, the therapeutic results also include reductions in inflammatory cytokines release, suppression of ETs‐activated danger signaling pathways, including toll‐like receptor 9 (TLR9) and nuclear factor‐kappa B (NF‐κB), as well as decreased mucous exudation and improved hearing functions. Comprehensively, transcriptomic analysis with RNA‐sequencing confirms that C‐TA H treatment significantly reverses the pathological gene expression changes after OVA sensitization. This work introduces an aptamer modification strategy for the target and capture of NETs/EETs, providing a potential therapeutic approach for modulating inflammatory signaling in OME as well as other recalcitrant inflammatory disorders.


  • Open Access

    Nanostructured organic sheets sequestering small extracellular vesicles and reactive species to protect against radiation-induced mucositis

    by Yuefei Zhu, Changyi Xu, Zhixin Li, Xiaomin Bao, Ming Liu, Yangyang She, Renqiang Ma, Xiangzhen Liu, Jian Li, Weiping Wen, et al.

    Radiation-induced mucositis significantly reduces quality of life in patients undergoing radiotherapy and chemoradiotherapy for head and neck cancer. Radiation exposure increases the secretion of small extracellular vesicles carrying double-stranded DNA, which triggers excessive inflammation. To address this, we develop functionalized organic nanosheets designed to capture these inflammatory vesicles from damaged tissue. Using template-based synthesis, we create nanostructured organic sheets functionalized with CD63 aptamers, enabling selective targeting of extracellular vesicles involved in mucositis. These nanosheets show enhanced vesicle-binding capacity compared to spherical nanoparticles, efficiently suppressing inflammation by inhibiting the stimulator of interferon genes activation in macrophages. Additionally, they effectively scavenge reactive oxygen and nitrogen species, further alleviating mucosal inflammation. Flow cytometry and transcriptome analyses in irradiated animal models confirm significant mucositis mitigation. This therapeutic platform provides a promising anti-inflammatory strategy by demonstrating how biomaterial geometry and surface functionalization can modulate small extracellular vesicle-mediated inflammation in radiation-induced mucositis.


  • Open Access

    Multifunctional Boron‐based 2D Nanoplatforms Ameliorate Severe Respiratory Inflammation by Targeting Multiple Inflammatory Mediators

    by Changyi Xu, Ming Liu, Xinran Xie, Zhixin Li, Yuefei Zhu, Yang Ye, Mengya Du, Suhua Hu, Tianrun Liu, Yubiao Guo, et al.

    Effective management of serious respiratory diseases, such as asthma and recalcitrant rhinitis, remains a global challenge. Here, it is shown that induced sputum supernatants (ISS) from patients with asthma contain higher levels of cell‐free DNA (cfDNA) compared to that of healthy volunteers. Although cfDNA scavenging strategies have been developed for inflammation modulation in previous studies, this fall short in clinical settings due to the excessive neutrophil extracellular trap (NET) formation, reactive oxygen and nitrogen species (RONS) and bacterial infections in injured airway tissues. Based on this, a multifunctional boron‐based 2D nanoplatform B‐PM is designed by coating boron nanosheets (B‐NS) with polyamidoamine generation 1 (PG1) dendrimer, which can simultaneously target cfDNA, NETs, RONS, and bacteria. The effects of B‐PM in promoting mucosal repair, reducing airway inflammation, and mucus production have been demonstrated in model mice, and the therapeutic effect is superior to dexamethasone. Furthermore, flow cytometry with clustering analysis and transcriptome analysis with RNA‐sequencing are adopted to comprehensively evaluate the in vivo anti‐inflammation therapeutic effects. These findings emphasize the significance of a multi‐targeting strategy to modulate dysregulated inflammation and highlight multifunctional boron‐based 2D nanoplatforms for the amelioration of respiratory inflammatory diseases.


  • Open Access

    Functional 2D Nanoplatforms Alleviate Eosinophilic Chronic Rhinosinusitis by Modulating Eosinophil Extracellular Trap Formation

    by Zhaoxu Tu, Ming Liu, Changyi Xu, Yi Wei, Tong Lu, Yongqiang Xiao, Hongxia Li, Shuaiyin Zhang, Xinran Xie, Jian Li, et al.

    The therapeutic outcomes of patients with eosinophilic chronic rhinosinusitis (ECRS) remain unsatisfactory, largely because the underlying mechanisms of eosinophilic inflammation are uncertain. Here, it is shown that the nasal secretions of ECRS patients have high eosinophil extracellular trap (EET) and cell‐free DNA (cfDNA) levels. Moreover, the cfDNA induced EET formation by activating toll‐like receptor 9 (TLR9) signaling. After demonstrating that DNase I reduced eosinophilic inflammation by modulating EET formation, linear polyglycerol‐amine (LPGA)‐coated TiS2 nanosheets (TLPGA) as functional 2D nanoplatforms with low cytotoxicity, mild protein adsorption, and increased degradation rate is developed. Due to the more flexible linear architecture, TLPGA exhibited higher cfDNA affinity than the TiS2 nanosheets coated with dendritic polyglycerol‐amine (TDPGA). TLPGA reduced cfDNA levels in the nasal secretions of ECRS patients while suppressing cfDNA‐induced TLR9 activation and EET formation in vitro. TLPGA displayed exceptional biocompatibility, preferential nasal localization, and potent inflammation modulation in mice with eosinophilic inflammation. These results highlight the pivotal feature of the linear molecular architecture and 2D sheet‐like nanostructure in the development of anti‐inflammation nanoplatforms, which can be exploited for ECRS treatment.


  • Tackling Severe Neutrophilic Inflammation in Airway Disorders with Functionalized Nanosheets

    by Zhaoxu Tu, Yuefei Zhu, Wenlong Gao, Ming Liu, Yi Wei, Changyi Xu, Yongqiang Xiao, Yihui Wen, Jian Li, Kam W. Leong, et al.

    Severe airway inflammatory disorders impose a significant societal burden, and the available treatments are unsatisfactory. High levels of neutrophil extracellular trap (NET) and cell-free DNA (cfDNA) were detected in the inflammatory microenvironment of these diseases, which are closely associated with persistent uncontrolled neutrophilic inflammation. Although DNase has proven to be effective in mitigating neutrophilic airway inflammation in mice by reducing cfDNA and NET levels, its clinical use is hindered by severe side effects. Here, we synthesized polyglycerol-amine (PGA) with a series of hydroxyl/amine ratios and covered them with black phosphorus (BP) nanosheets. The BP nanosheets functionalized with polyglycerol-50% amine (BP-PGA50) efficiently lowered cfDNA levels, suppressed toll-like receptor 9 (TLR9) activation and inhibited NET formation in vitro. Importantly, BP-PGA50 nanosheets demonstrated substantial accumulation in inflamed airway tissues, excellent biocompatibility, and potent inflammation modulation ability in model mice. The 2D sheet-like structure of BP-PGA50 was identified as a crucial factor for the therapeutic efficacy, and the hydroxyl/amine ratio was revealed as a significant parameter to regulate the protein resistance, cfDNA-binding efficacy, and cytotoxicity. This study shows the promise of the BP-PGA50 nanosheet for tackling uncontrolled airway inflammation, which is also significant for the treatment of other neutrophilic inflammatory diseases. In addition, our work also highlights the importance of proper surface functionalization, such as hydroxyl/amine ratio, in therapeutic nanoplatform construction for inflammation modulation.